Tekla Capital Management LLC cut its holdings in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 36.0% in the 4th quarter, Holdings Channel reports. The firm owned 100,422 shares of the biotechnology company’s stock after selling 56,453 shares during the period. Tekla Capital Management LLC’s holdings in Arrowhead Pharmaceuticals were worth $4,073,000 at […]
SVB Leerink cut shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Rating) from an outperform rating to a market perform rating in a research note released on Friday morning, PriceTargets.com reports. Several other analysts also recently commented on ARWR. SVB Securities downgraded shares of Arrowhead Pharmaceuticals from an outperform rating to a market perform rating and […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Retirement Systems of Alabama grew its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 0.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 332,712 shares of the biotechnology company’s stock after acquiring an additional 936 shares during the period. Retirement Systems of […]
Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) have received an average rating of “Moderate Buy” from the fourteen ratings firms that are currently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year price […]